Did not become law. It stopped in the Senate's Drug Policy Committee on February 28, 2017. The 2017 session has ended.
2017 Regular Session
House Bill 1031
Drug Schedules I, II and III; revise.
What it does
The synopsis the Legislature published with the bill.
AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, TO REVISE SCHEDULE I TO INCLUDE AH-7921, BUTYRYL FENTANYL AND BETA-HYDROXYTHIOFENTANYL; TO AMEND SECTIONS 41-29-115 AND 41-29-117, MISSISSIPPI CODE OF 1972, TO EXCLUDE PENTAZOCINE, A SCHEDULE IV DRUG, FROM LISTING ON SCHEDULES II AND III; TO AMEND SECTION 41-29-119, MISSISSIPPI CODE OF 1972, TO REVISE SCHEDULE IV TO INCLUDE ELUXADOLINE; TO AMEND SECTION 41-29-121, MISSISSIPPI CODE OF 1972, TO REVISE SCHEDULE V TO INCLUDE BRIVARACETAM; AND FOR RELATED PURPOSES.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
Its course
January 16 to February 28, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action6 actions on 6 days
In the House of RepresentativesJan 16 to Feb 722 days
Drug PolicyJan 16 to Jan 259 days
In the SenateFeb 7 to Feb 28 · stopped21 days
Drug PolicyFeb 15 to Feb 28 · stopped13 days
Text
Each version as the Legislature printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislature published it is below.
In the House of Representatives Jan 16 – Feb 7
- Jan 16Referred to the House committee on Drug Policy
- Jan 25Reported from committee in the House: title sufficient, do pass
- Feb 7Passed the House
In the Senate Feb 8 – Feb 28
- Feb 8Sent to the Senate
- Feb 15Referred to the Senate committee on Drug Policy
- Feb 28Died in committee in the Senate
All 6 actions, as published
- Jan 16Referred To Drug PolicyHouse of Representatives
- Jan 25Title Suff Do PassHouse of Representatives
- Feb 7PassedHouse of Representatives
- Feb 8Transmitted To SenateHouse of Representatives
- Feb 15Referred To Drug PolicySenate
- Feb 28Died In CommitteeSenate